| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
SENNIDINE B
|
517-44-2 |
番泻甙元B
|
番泻苷元B;番泻甙元B;番泻苷元B
|
C30H18O10 |
538.46 | 208-239-4 |
|
Vaccarin
|
53452-16-7 |
王不留行黄酮苷
|
王不留行黄酮苷对照品;王不留行黄酮苷;王不留行黄酮苷(标准品);王不留行黄酮甘;王不留行黄酮甙;王不留行黄酮苷 (王不留行黄酮甙);VACCARIN 王不留行黄酮苷;王不留行黄酮苷,来源于王不留行
|
C32H38O19 |
727 | |
|
TCN 238
|
125404-04-8 |
TCN 238
|
TCN 238; TCN-238
|
C12H11N3 |
197.23584 | |
|
PD 184161
|
212631-67-9 |
/
|
|
C13H23NO6 |
289.32482 | |
|
BMS-794833
|
1174046-72-0 |
BMS-794833
|
N-[4-((2-氨基-3-氯吡啶-4-基)氧基)-3-氟苯基]-5-(4-氟苯基)-4-氧代-1,4-二氢吡啶-3-甲酰胺;N-[4-[(2-氨基-3-氯-4-吡啶)氧基]-3-氟苯基]-5-(4-氟苯基)-1,4-二氢-4-氧代-3-吡啶羧酰胺
|
C23H15ClF2N4O3 |
468.840006 | |
|
Albaspidin AP
|
59092-91-0 |
白绵马素AP
|
白绵马素AP
|
C22H26O8 |
418.43704 | |
|
PF 477736
|
952021-60-2 |
PF 477736
|
CS-237;Α-氨基-N-[5,6-二氢-2-(1-甲基-1H-吡唑-4-基(-6-氧代-1H-吡咯并[4,3,2-EF][2,3]苯并二氮杂革-8-基]-环己烷乙酰胺;PF 477736;PF-477736;PF477736;(ALPHAR(-ALPHA-氨基-N-[5,3]苯并二氮杂卓-8-基]环己烷乙酰胺
|
C22H24N7O2 |
418.47166 | |
|
IPA-3
|
42521-82-4 |
IPA-3
|
IPA 3;IPA3;二(2-羟基-1-萘基)二硫醚
|
C20H14O2S2 |
350 | |
|
L 006235
|
294623-49-7 |
/
|
L-006235;L 006235;L006235
|
C24H30N6O2S |
467 | |
|
GSK-3787
|
188591-46-0 |
GSK-3787
|
4-氯-N-[2-[[5-(三氟甲基)-2-吡啶基]磺酰基]乙基]-苯甲酰胺;GSK3787;GSK 3787;GSK-3787;CS-710
|
C15H12ClF3N2O3S |
393 | |
|
PF-3845
|
1196109-52-0 |
PF 3845
|
N-3-吡啶基-4-[[3-[[5-(三氟甲基)-2-吡啶基]氧基]苯基]甲基]-1-哌啶甲酰胺;PF-3845 N-3-吡啶-4-[[3-[[5-(三氟甲基)-2-吡啶]氧基]苯基]甲基]-1-哌啶羧酰胺;CS-124;N-3-吡啶-4-[[3-[[5-(三氟甲基)-2-吡啶]氧基]苯基]甲基]-1-哌啶羧酰胺;PF-3845;PF 3845;PF3845
|
C24H23F3N4O2 |
456 | |
|
MC1568
|
852475-26-4 |
MC1568
|
3-[4-[3-(3-氟苯基)-3-氧代-1-丙烯基]-1-甲基-1H-吡咯-2-基]-N-羟基-2-丙烯酰胺
|
C17H15FN2O3 |
314.3110032 | |
|
XL147
|
956958-53-5 |
XL147
|
N-[3-(2,1,3-苯并噻二唑-5-氨基)-2-喹喔啉基]-4-甲基苯磺酰胺;N-[3-(苯并[C] [1,2,5]噻二唑-5-基氨基)喹喔啉-2-基]-4-甲基苯磺酰胺;XL147 类似物
|
C21H16N6O2S2 |
448.52074 | |
|
Tie2 kinase inhibitor
|
948557-43-5 |
Tie2 kinase inhibitor
|
Tie2 kinase-IN-1;4-(6-Methoxy-2-naphthyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole;Tie2 kinase inhibitor;4-[4-(6-Methoxy-2-naphthalenyl)-2-[4-(Methylsulfinyl)phenyl]-1H-iMidazol-5-yl]pyridine;4-(5-(6-methoxynaphthalen-2-yl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)pyridine;4-(4-(6-Methoxynaphthalen-2-yl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-5-yl)pyridine
|
C26H21N3O2S |
439.52884 | |
|
Danoprevir (RG7227)
|
850876-88-9 |
丹诺普韦
|
RG72277;Itmn-191 Danoprevir;(2R,6S,13aS,14aR,16aS,E)-6-((tert-butoxycarbonyl)aMino)-14a-((cyclopropylsulfonyl)carbaMoyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 4-fluoroisoindoline-2-carboxylate;R7227;RG7227;RO5190591;Danoprevir (RG7227);Danoprevir(ITMN-191, RG7227)
|
C35H46FN5O9S |
||
|
BMS-754807
|
1001350-96-4 |
BMS-754807
|
(2S)-1-[4-[(5-环丙基-1H-吡唑-3-基)氨基]吡咯并[2,1-F][1,2,4]三嗪-2-基]-N-(6-氟-3-吡啶基)-2-甲基-2-吡咯烷甲酰胺
|
C23H24FN9O |
461.51 | |
|
1-cyclopropyl-3-[(3Z)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea
|
896466-04-9 |
AT9283
|
CS-48;AT-9283;AT 9283;1-环丙基-3-(3-(5-(吗啉甲基)-1H-苯并[D]咪唑-2-基)-1H-吡唑-4-基)脲
|
C19H23N7O2 |
381.43162 | |
|
PHA-680632
|
398493-79-3 |
PHA-680632
|
CS-411;N-(2,6-二乙基苯基)-4,6-二氢-3-[[4-(4-甲基-1-哌嗪基)苯甲酰基]氨基]吡咯并[3,4-C]吡唑-5(1H)-甲酰胺;PHA-680632;PHA680632;PHA 680632
|
C28H35N7O2 |
501.62 | |
|
Okadaic acid
|
78111-17-8 |
冈田(软海绵)酸
|
35-去甲基鳍藻毒素 1;软海绵酸(>95.0%,BC);冈田(软海绵)酸溶液,10PPM;大田软海绵酸;冈田酸游离酸;软海绵酸,游离酸;冈田(软海绵)酸;冈田酸
|
C44H68O13 |
805 | 616-589-8 |
|
PHA-767491
|
845714-00-3 |
PHA767491
|
CAY10572(PHA-767491);PHA 767491 HYDROCHLORIDE;1,5,6,7-Tetrahydro-2-(4-pyridinyl)-4H-pyrrolo[3,2-c]pyridin-4-onehydrochloride;PHA-767491;CAY10572;1,5,6,7-Tetrahydro-2-(4-pyridinyl)-4H-pyrrolo[3,2-c]pyridin-4-one;2-(pyridin-4-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one;PHA-767491HCL
|
C12H11N3O.ClH |
249.7 |
药智官方微信
药智官方微博
